French tighten control over mammography equipment:
This article was originally published in Clinica
Executive Summary
The French Healthcare Products Safety Agency (AFSSAPS) has published a Decision aimed at ensuring tighter quality control of all imaging equipment used in mammography and in the interpretation of mammograms. All technicians in this area have six months to install full quality control of the devices used in this area. The decision is part of the government's new breast screening programme, which aims to ensure that all 50-69 year old women in France receive mammography screening every other year.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.